~ Chronic Pain Sufferer Number Used to Justify FDA Approval for Narcotic PainKillers Is Misleading - Zohydro: A Case-in-Point

~ Chronic Pain Sufferer Number Used to Justify FDA Approval for Narcotic PainKillers Is Misleading - Zohydro: A Case-in-Point
John Fauber, Reporter, Milwaukee Journal Sentinel/MedPage Today reports that conflict of interest may be at play in the use - or misuse - of a widely used number cited by drug cmpanies seeking approval for new narcotic painkillers.

This has recently come up in conjuction of the FDA's approval of the drug Zohydro - an approval that more and more health professionals think should be resceinded.

In defense of approving this drug, FDA commissioner Margaret Hamburg cited the statistic that 100 million American adults suffer from debilitating and severe chronic pain.

But this number has been challenged by experts its origins in the 2011 report: "Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research" (http://www.iom.edu/Reports/2011/Relieving-Pain-in-America-A-Blueprint-for-transforming-Prevention-Care-Education-Research.aspx)

Moreover, Journal Sentinel/MedPage Today uncovered that 19 experts on the panel that produced the report "...had connections to companies that manufacture narcotic painkillers at the time or in the 3 years prior to their work on the report."

These connections were not disclosed in the report, and the U.S. Senate is investigating the role of these links in the approval of Zohydro (Manchin Confronts FDA Approval of Zohydro and Pay-to-Play Scheme with FDA Commissioner Hamburg Prior to Committee Hearing, http://www.manchin.senate.gov/public/index.cfm/2014/3/manchin-confronts-fda-approval-of-zohydro-and-pay-to-play-scheme-with-fda-commissioner-hamburg-prior-to-committee-hearing)

Phsycians and health advocates are not only debating the safety of the drug, but the 100 million number itself -- using an overstated number to represent the kind of pain extreme measures should be taken for dangerously undermines their entire credibility.

Here is a video of some of that discussion: http://bit.ly/1nFafnp

Source: IOM and COI: Painful Disclosures?, Published: Jun 25, 2014 | Updated: Jun 25, 2014, By John Fauber, Reporter, Milwaukee Journal Sentinel/MedPage Today

Free Shipping in the Continental U.S. on Orders over $50
The statements made here have not been evaluated by the FDA. The foregoing statements are based upon sound and reliable studies, and are meant for informational purposes. Consult with your medical practitioner to determine the underlying cause of your symptoms. Please always check your purchase for possible allergins and correct dosage on the bottle before use.

While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on our Web site. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Life Ex Online assumes no liability for inaccuracies or misstatements about products.